Literature DB >> 92180

Viral xenogenization of intact tumor cells.

H Kobayashi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92180     DOI: 10.1016/s0065-230x(08)60899-4

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  22 in total

1.  Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Authors:  H Schild; P von Hoegen; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen.

Authors:  J Nowak; E P Cohen; L H Graf
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia.

Authors:  J S Bryson; D C Cox
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 5.  Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.

Authors:  V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Susceptibility of Marek's disease lymphoblastoid cell lines to infection with influenza and pseudorabies viruses and the protective effect of immunization with influenza virus-infected lymphoblastoid cells.

Authors:  L J Ross; J M Bumstead; P C Powell
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity.

Authors:  V Schirrmacher; R Heicappell
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

8.  Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.

Authors:  K Yamashina; T Oikawa; M Kasai; M Naiki; I Chiba; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.

Authors:  B Nardelli; A R Contessa; L Romani; G Sava; C Nisi; M C Fioretti
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.

Authors:  J A Byrne; M Soloski; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.